TrialNature medicine2024

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Hedyeh Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.